News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Daily News Nonfatal MI Not a Death Surrogate in Cardiology: Meta-analysis Caitlin E. Cox October 27, 2021
News Conference News AHA Announces Fully Virtual Meeting in Light of Surging COVID-19 Numbers Michael O'Riordan September 17, 2021
News Opinion Over the Wire Trust and Transparency: From Ancient Rome to Guideline Committees Mamas Mamas, BMBCh April 29, 2021
News Conference News AHA, Editors, and Cardiologists Ask: How Did ‘Racist’ Paper Make It to Print? Michael O'Riordan August 05, 2020
News Opinion Off Script COVID-19 Begs the Question: If Medical Meetings Go Virtual, What Do We Gain and Lose? Asif Qasim, MB BChir, PhD March 06, 2020
News Conference News STS 2020 TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge Yael L. Maxwell January 29, 2020
News Opinion Editor's Corner ISCHEMIA Questions? Some Answers From David Maron Shelley Wood December 09, 2019
News Features Subtherapeutic Heparin: As Stories Multiply, Concerns Mount Yael L. Maxwell November 27, 2019
News Conference News TCT 2019 #CardioQuiz Engages Cardiology Learners Through Twitter Polls, Discussion Yael L. Maxwell October 03, 2019
News Conference News SCAI 2019 TAVR Operators: Can One Do It All or Are Two Still Justified? Yael L. Maxwell June 04, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2019 Caitlin E. Cox May 31, 2019
News Conference News TCT 2018 Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos Michael O'Riordan October 02, 2018
News Daily News ‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions Yael L. Maxwell August 17, 2018
News Opinion Fellow Talk Why All Interventionalists Should Be on Twitter Amit K. Gupta, MBBS, MD October 18, 2017
News Daily News Medical Journal Editors Back Off Ambitious Data-Sharing Mandate for Publication Shelley Wood June 07, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017